Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study
Lidia Serrano Díaz; Carles Iniesta Navalón; Rosa Gómez Espín; Isabel Nicolás De Prado; Enrique Bernal Morell; Lorena Rentero Redondo;
Gastroenterol Hepatol. 2024;47:553-61
Headache in patients with inflammatory bowel disease: Migraine prevalence according to the Migraine Screening-Questionnaire (MS-Q) and headache characteristics
Alicia Gonzalez-Martinez; Inés Muro; Sonia Quintas; María Chaparro; Javier P. Gisbert; Ancor Sanz-García; María José Casanova; Cristina Rubín de Célix; José Vivancos; Ana Beatriz Gago-Veiga;
Gastroenterol Hepatol. 2024;47:63-71
Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease
Mónica R. Zavala-Solares; Lucero Salazar-Salas; Jesus K. Yamamoto-Furusho;
Gastroenterol Hepatol. 2021;44:711-8